DIAMEDICA THERAPEUTICS INC (DMAC) Stock Earnings & Estimates
USA - NASDAQ:DMAC - CA25253X2077 - Common Stock
6.96 USD
-0.11 (-1.56%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 500K | -100.00% | 5.684M | 42.95M 655.63% | 85.404M 98.85% | 130.82M 53.18% | 165.73M 26.69% | 195.84M 18.17% | ||||||||||
| EBITDA YoY % growth | -2.479M -71.90% | -4.515M -82.11% | -6.746M -49.41% | -11.233M -71.54% | -11.016M -9.56% | N/A -7.45% | N/A -2.60% | -21.216M -51.95% | -26.622M -25.45% | -35.598M -33.62% | -43.962M -23.50% | -46.41M -5.57% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.482M -71.52% | -4.519M -82.11% | -6.761M -49.61% | -12.09M -71.47% | -12.107M -9.54% | -15.531M -7.46% | -14.069M -2.60% | -21.46M -51.90% | -26.539M -25.46% | -33.9M -27.06% | -40.432M -19.27% | -44.542M -10.17% | -19.894M 55.34% | 11.009M 155.34% | 42.693M 287.80% | 69.605M 63.04% | 95.339M 36.97% | |
| Operating Margin | N/A | N/A | -1,352.20% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -783.64% | -46.32% | 12.89% | 32.63% | 42.00% | 48.68% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.95 -9.07% | -0.74 12.36% | -0.74 17.95% | -0.53 18.75% | -0.62 -19.23% | -0.60 3.23% | -0.69 -15.60% | -0.76 -9.31% | -0.74 2.47% | -0.35 53.10% | 0.18 152.94% | 0.63 244.44% | 1.01 59.68% | 1.37 35.35% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 -8.80% | -0.17 5.55% | -0.20 -13.33% | -0.20 -13.33% | -0.22 -37.50% | -0.22 -32.00% | -0.17 15.00% | -0.17 15.00% | -0.17 22.73% | -0.17 22.73% |
| Revenue Q2Q % growth | ||||||||||
| EBITDA Q2Q % growth | -8.874M -29.45% | -9.894M -18.07% | -10.506M -29.18% | -10.506M -31.44% | -11.526M -29.89% | -11.526M -16.49% | -11.628M -10.68% | -11.628M -10.68% | -11.628M -0.88% | -11.628M -0.88% |
| EBIT Q2Q % growth | -8.496M -23.43% | -8.931M -6.08% | -10.506M -29.00% | -10.506M -31.21% | -11.526M -35.67% | -11.526M -29.05% | -11.628M -10.68% | -11.628M -10.68% | -11.628M -0.88% | -11.628M -0.88% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.18 -38.46% | -0.19 | 0.01 | 7.12% |
| Q1 2025 Q2Q % growth | -0.18 -28.57% | -0.18 | 0.00 | 1.96% |
| Q4 2024 Q2Q % growth | -0.18 -28.57% | -0.18 | 0.00 | -2.30% |
| Q3 2024 Q2Q % growth | -0.15 -25.00% | -0.16 | 0.01 | 5.12% |
| Q2 2024 Q2Q % growth | -0.13 18.75% | -0.16 | 0.03 | 18.65% |
| Q1 2024 Q2Q % growth | -0.14 30.00% | -0.16 | 0.02 | 12.39% |
| Q4 2023 Q2Q % growth | -0.14 | -0.14 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.12 | -0.13 | 0.01 | 7.12% |
| Q2 2023 Q2Q % growth | -0.16 -23.08% | -0.18 | 0.02 | 11.21% |
| Q1 2023 Q2Q % growth | -0.20 -53.85% | -0.16 | -0.04 | -22.55% |
| Q4 2022 Q2Q % growth | -0.14 -40.00% | -0.14 | 0.00 | 1.96% |
| Q3 2022 Q2Q % growth | -0.12 33.33% | -0.15 | 0.03 | 20.24% |
| Q2 2022 Q2Q % growth | -0.13 23.53% | -0.18 | 0.05 | 29.19% |
| Q1 2022 Q2Q % growth | -0.13 31.58% | -0.22 | 0.09 | 40.26% |
| Q4 2021 Q2Q % growth | -0.10 56.52% | -0.18 | 0.08 | 44.30% |
| Q3 2021 Q2Q % growth | -0.18 5.26% | -0.23 | 0.05 | 22.60% |
| Q2 2021 Q2Q % growth | -0.17 | -0.22 | 0.05 | 21.26% |
| Q1 2021 Q2Q % growth | -0.19 | -0.22 | 0.03 | 12.68% |
| Q4 2020 Q2Q % growth | -0.23 -9.52% | -0.17 | -0.06 | -34.22% |
| Q3 2020 Q2Q % growth | -0.19 5.00% | -0.15 | -0.04 | -27.00% |
| Q2 2020 Q2Q % growth | -0.17 19.05% | -0.16 | -0.01 | -8.70% |
| Q1 2020 Q2Q % growth | -0.19 29.63% | -0.29 | 0.10 | 34.26% |
| Q4 2019 Q2Q % growth | -0.21 | -0.25 | 0.04 | 17.21% |
| Q3 2019 Q2Q % growth | -0.20 | -0.21 | 0.01 | 6.63% |
| Q2 2019 Q2Q % growth | -0.21 | -0.26 | 0.05 | 19.79% |
| Q1 2019 Q2Q % growth | -0.27 | -0.20 | -0.07 | -32.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 18.65% | 0% | 12.45% |
| Revenue | N/A | N/A | N/A | N/A |